Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: Potent targets for cancer stem cell therapy

References

• Zhang F, Song C, Ma Y, Tang L, Xu Y, Wang H. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression. Int J Mol Med 2011;28:365–71
   PubMed Web of Science ®Google Scholar
• Shahi P, Seethammagari MR, Valdez JM, Xin L, Spencer DM. Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation. Stem Cells 2011;29:678–88
   PubMed Web of Science ®Google Scholar
• Li G, Zhao F, Cui Y. Proteomics using mammospheres as a model system to identify proteins deregulated in breast cancer stem cells. Curr Mol Med 2013;13:459–63
   PubMed Web of Science ®Google Scholar
• Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PloS One 2008;3:e2428
   PubMed Web of Science ®Google Scholar
• Hsu CS, Tung CY, Yang CY, Lin CH. Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620. PloS One 2013;8:e61133
   PubMed Web of Science ®Google Scholar
• Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med 2013;2:3
   PubMedGoogle Scholar
• Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, et al. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst 2010;102:1637–52
   PubMedGoogle Scholar
• Achuthan S, Santhoshkumar TR, Prabhakar J, Nair SA, Pillai MR. Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species. J Biol Chem 2011;286:37813–29
   PubMed Web of Science ®Google Scholar
• Foster BA, Gangavarapu KJ, Mathew G, Azabdaftari G, Morrison CD, Miller A, et al. Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. PloS One 2013;8:e55062
   PubMed Web of Science ®Google Scholar
• Nakatsugawa M, Takahashi A, Hirohashi Y, Torigoe T, Inoda S, Murase M, et al. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest 2011;91:1796–804
   PubMed Web of Science ®Google Scholar
• Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, et al. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. J Urol 2012;188:294–9
   PubMed Web of Science ®Google Scholar
• Nishizawa S, Hirohashi Y, Torigoe T, Takahashi A, Tamura Y, Mori T, et al. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res 2012;72:2844–54
   PubMed Web of Science ®Google Scholar
• Nishida S, Hirohashi Y, Torigoe T, Inoue R, Kitamura H, Tanaka T, et al. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor. Cancer Sci 2013;104:431–6
   PubMed Web of Science ®Google Scholar
• Morita R, Hirohashi Y, Suzuki H, Takahashi A, Tamura Y, Kanaseki T, et al. DNA methyltransferase 1 is essential for initiation of the colon cancers. Exp Mol Pathol 2013;94:322–9
   PubMed Web of Science ®Google Scholar
• Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;99:507–12
   PubMed Web of Science ®Google Scholar
• Yamada R, Takahashi A, Torigoe T, Morita R, Tamura Y, Tsukahara T, et al. Preferential expression of cancer/testis genes in cancer stem-like cells: Proposal of a novel sub-category, cancer/testis/stem gene. Tissue Antigens 2013;81:428–34
   Google Scholar
• Caballero OL, Chen YT. Cancer/testis (CT) antigens: Potential targets for immunotherapy. Cancer Sci 2009;100:2014–21
   PubMed Web of Science ®Google Scholar
• Lage H, Jordan A, Scholz R, Dietel M. Thermosensitivity of multidrug-resistant human gastric and pancreatic carcinoma cells. Int J Hyperthermia 2000;16:291–303
   PubMed Web of Science ®Google Scholar
• Caldera V, Mellai M, Annovazzi L, Monzeglio O, Piazzi A, Schiffer D. MGMT hypermethylation and MDR system in glioblastoma cancer stem cells. Cancer Genomics Proteomics 2012;9:171–8
   PubMed Web of Science ®Google Scholar
• Vukovic J, Bedin AS, Bartlett PF, Osborne GW. A novel fluorescent reporter CDy1 enriches for neural stem cells derived from the murine brain. Stem Cells Dev 2013; epub ahead of print. DOI: 10.1089/scd.2012.0660
   Google Scholar
• Hawley TS, Riz I, Yang W, Wakabayashi Y, Depalma L, Chang YT, et al. Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. Am J Hematol 2013;88:265–72
   PubMed Web of Science ®Google Scholar
• Gangavarpu KJ, Huss WJ. Isolation and applications of prostate side population cells based on dye cycle violet efflux. Curr Protoc Toxicol 2011;22:22
   Google Scholar
• Saini V, Hose CD, Monks A, Nagashima K, Han B, Newton DL, et al. Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma. PloS One 2012;7:e41401
   PubMed Web of Science ®Google Scholar
• Hsu LC, Chang WC, Hoffmann I, Duester G. Molecular analysis of two closely related mouse aldehyde dehydrogenase genes: Identification of a role for Aldh1, but not Aldh-pb, in the biosynthesis of retinoic acid. Biochem J 1999;339:387–95
   PubMed Web of Science ®Google Scholar
• Rhinn M, Dolle P. Retinoic acid signalling during development. Development (Cambridge) 2012;139:843–58
   PubMed Web of Science ®Google Scholar
• Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006;24:975–85
   PubMed Web of Science ®Google Scholar
• Ikawa M, Impraim CC, Wang G, Yoshida A. Isolation and characterization of aldehyde dehydrogenase isozymes from usual and atypical human livers. J Biol Chem 1983;258:6282–7
   PubMed Web of Science ®Google Scholar
• Hellsten R, Johansson M, Dahlman A, Sterner O, Bjartell A. Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells. PloS One 2011;6:e22118
   PubMed Web of Science ®Google Scholar
• Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555–67
   PubMed Web of Science ®Google Scholar
• Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, et al. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res 2011;71:7226–37
   PubMed Web of Science ®Google Scholar
• Ucar D, Cogle CR, Zucali JR, Ostmark B, Scott EW, Zori R, et al. Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact 2009;178:48–55
   PubMed Web of Science ®Google Scholar
• Wei L, Liu TT, Wang HH, Hong HM, Yu AL, Feng HP, et al. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kappaB. Breast Cancer Res 2011;13:R101
   PubMed Web of Science ®Google Scholar
• Sreerama L, Sladek NE. Cellular levels of class 1 and class 3 aldehyde dehydrogenases and certain other drug-metabolizing enzymes in human breast malignancies. Clin Cancer Res 1997;3:1901–14
   PubMed Web of Science ®Google Scholar
• Bohren KM, Bullock B, Wermuth B, Gabbay KH. The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem 1989;264:9547–51
   PubMed Web of Science ®Google Scholar
• Seo DC, Sung JM, Cho HJ, Yi H, Seo KH, Choi IS, et al. Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer 2007;6:75
   PubMed Web of Science ®Google Scholar
• Nomura M, Fukuda T, Fujii K, Kawamura T, Tojo H, Kihara M, et al. Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study. J Clin Bioinforma 2011;1:23
   PubMedGoogle Scholar
• Ahmed MM, Wang T, Luo Y, Ye S, Wu Q, Guo Z, et al. Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity. Hepatology 2011;54:1322–32
   PubMed Web of Science ®Google Scholar
• Desmond JC, Mountford JC, Drayson MT, Walker EA, Hewison M, Ride JP, et al. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res 2003;63:505–12
   PubMed Web of Science ®Google Scholar
• Ruiz FX, Porte S, Pares X, Farres J. Biological role of aldo-keto reductases in retinoic acid biosynthesis and signaling. Frontiers Pharmacol 2012;3:58
   PubMed Web of Science ®Google Scholar
• Jung KA, Choi BH, Nam CW, Song M, Kim ST, Lee JY, et al. Identification of aldo-keto reductases as NRF2-target marker genes in human cells. Toxicol Lett 2013;218:39–49
   PubMed Web of Science ®Google Scholar
• Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009;284:13291–5
   PubMed Web of Science ®Google Scholar
• Tsai JJ, Dudakov JA, Takahashi K, Shieh JH, Velardi E, Holland AM, et al. Nrf2 regulates haematopoietic stem cell function. Nat Cell Biol 2013;15:309–16
   PubMed Web of Science ®Google Scholar
• Kim HY, Gladyshev VN. Methionine sulfoxide reductases: Selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem J 2007;407:321–9
   PubMed Web of Science ®Google Scholar
• Lee BC, Dikiy A, Kim HY, Gladyshev VN. Functions and evolution of selenoprotein methionine sulfoxide reductases. Biochim Biophys Acta 2009;1790:1471–7
   PubMed Web of Science ®Google Scholar
• Ferguson LR, Karunasinghe N, Zhu S, Wang AH. Selenium and its role in the maintenance of genomic stability. Mutat Res 2012;733:100–10
   PubMed Web of Science ®Google Scholar
• Sedding DG. FoxO transcription factors in oxidative stress response and ageing – A new fork on the way to longevity? Biol Chem 2008;389:279–83
   PubMed Web of Science ®Google Scholar
• Zhang X, Rielland M, Yalcin S, Ghaffari S. Regulation and function of FoxO transcription factors in normal and cancer stem cells: What have we learned? Curr Drug Targets 2011;12:1267–83
   PubMed Web of Science ®Google Scholar
• Eijkelenboom A, Burgering BM. FOXOs: Signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 2013;14:83–97
   PubMed Web of Science ®Google Scholar
• Sunayama J, Sato A, Matsuda K, Tachibana K, Watanabe E, Seino S, et al. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity. Stem Cells 2011;29:1327–37
   PubMed Web of Science ®Google Scholar
• Calderwood SK. Heat shock proteins in breast cancer progression – A suitable case for treatment? Int J Hyperthermia 2010;26:681–5
   PubMed Web of Science ®Google Scholar
• Noonan EJ, Place RF, Giardina C, Hightower LE. Hsp70B′ regulation and function. Cell Stress Chaperones 2007;12:219–29
   PubMed Web of Science ®Google Scholar
• Le Masson F, Christians E. HSFs and regulation of Hsp70.1 (HSPA1B) in oocytes and preimplantation embryos: New insights brought by transgenic and knockout mouse models. Cell Stress Chaperones 2011;16:275–85
   PubMed Web of Science ®Google Scholar
• Wilkerson DC, Murphy LA, Sarge KD. Interaction of HSF1 and HSF2 with the HSPA1B promoter in mouse epididymal spermatozoa. Biol Reprod 2008;79:283–8
   PubMed Web of Science ®Google Scholar
• Mendillo ML, Santagata S, Koeva M, Bell GW, Hu R, Tamimi RM, et al. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell 2012;150:549–62
   PubMed Web of Science ®Google Scholar
• Newman B, Liu Y, Lee HF, Sun D, Wang Y. HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells. Cancer Res 2012;72:4551–61
   PubMed Web of Science ®Google Scholar
• Whitesell L, Lindquist S. Inhibiting the transcription factor HSF1 as an anticancer strategy. Expert Opin Therapeut Targets 2009;13:469–78
   PubMed Web of Science ®Google Scholar
• Wierenga PK, Konings AW. Effect of a hyperthermic treatment on the pluripotent haemopoietic stem cell in normal and anaemic mice. Int J Hyperthermia 1990;6:793–800
   PubMed Web of Science ®Google Scholar
• Hirohashi Y, Torigoe T, Inoda S, Takahashi A, Morita R, Nishizawa S, et al. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Immunotherapy 2010;2:201–11
   PubMed Web of Science ®Google Scholar
• Cappell KM, Sinnott R, Taus P, Maxfield K, Scarbrough M, Whitehurst AW. Multiple cancer testis antigens function to support tumor cell mitotic fidelity. Mol Cell Biol 2012;32:4131–40
   PubMed Web of Science ®Google Scholar
• Chou SD, Prince T, Gong J, Calderwood SK. mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis. PloS One 2012;7:e39679
   PubMed Web of Science ®Google Scholar